Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H BUCHWALD

Showing results (101-110 of 110) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 110 results.
Journal of Clinical Epidemiology|January 1, 1989
Program on the Surgical Control of the Hyperlipidemias (POSCH): design and methodology. POSCH GroupH Buchwald, J P Matts, L L Fitch, et al.
The New England Journal of Medicine|October 4, 1990
Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia. Report of the Program on the Surgical Control of the Hyperlipidemias (POSCH)H Buchwald, R L Varco, J P Matts, et al.
JAMA|September 16, 1992
Changes in sequential coronary arteriograms and subsequent coronary events. Surgical Control of the Hyperlipidemias (POSCH) GroupH Buchwald, J P Matts, L L Fitch, et al.
Controlled Clinical Trials|April 11, 1991
Program on the Surgical Control of the Hyperlipidemias (POSCH): patient entry characteristics. The POSCH GroupJ P Matts, H Buchwald, L L Fitch, et al.
Journal of Clinical Epidemiology|March 1, 1995
Subgroup analyses of the major clinical endpoints in the Program on the Surgical Control of the Hyperlipidemias (POSCH): overall mortality, atherosclerotic coronary heart disease (ACHD) mortality, and ACHD mortality or myocardial infarctionJ P Matts, H Buchwald, L L Fitch, et al.
Diabetes Care|March 1, 1980
A totally implantable drug infusion defice: laboratory and clinical experience using a model with single flow rate and new design for modulated insulin infusionH Buchwald, T D Rohde, F D Dorman, et al.
International Journal of Obesity (2005)|February 28, 2007
Inter-disciplinary European guidelines on surgery of severe obesityM Fried, V Hainer, A Basdevant, et al.
Archives of Internal Medicine|June 13, 1998
Effective lipid modification by partial ileal bypass reduced long-term coronary heart disease mortality and morbidity: five-year posttrial follow-up report from the POSCH. Program on the Surgical Control of the HyperlipidemiasH Buchwald, R L Varco, J R Boen, et al.
Surgery|October 1, 1982
The Program on the Surgical Control of the Hyperlipidemias: a status reportH Buchwald, R B Moore, J P Matts, et al.
Journal of Medicinal Chemistry|April 1, 2026
An Optimized Route to the Syringolin Natural Products Enables Combinatorial Synthesis of Selective, Bioactive Inhibitors of the <i><i>Plasmodium falciparum</i></i> 20S ProteasomeXilin Gu, Pavla Fajtova, Nicholas L Yan, et al.
Pageof 11

Showing results (101-110 of 110) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 110 results.
Journal of Clinical Epidemiology|January 1, 1989
Program on the Surgical Control of the Hyperlipidemias (POSCH): design and methodology. POSCH GroupH Buchwald, J P Matts, L L Fitch, et al.
The New England Journal of Medicine|October 4, 1990
Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia. Report of the Program on the Surgical Control of the Hyperlipidemias (POSCH)H Buchwald, R L Varco, J P Matts, et al.
JAMA|September 16, 1992
Changes in sequential coronary arteriograms and subsequent coronary events. Surgical Control of the Hyperlipidemias (POSCH) GroupH Buchwald, J P Matts, L L Fitch, et al.
Controlled Clinical Trials|April 11, 1991
Program on the Surgical Control of the Hyperlipidemias (POSCH): patient entry characteristics. The POSCH GroupJ P Matts, H Buchwald, L L Fitch, et al.
Journal of Clinical Epidemiology|March 1, 1995
Subgroup analyses of the major clinical endpoints in the Program on the Surgical Control of the Hyperlipidemias (POSCH): overall mortality, atherosclerotic coronary heart disease (ACHD) mortality, and ACHD mortality or myocardial infarctionJ P Matts, H Buchwald, L L Fitch, et al.
Diabetes Care|March 1, 1980
A totally implantable drug infusion defice: laboratory and clinical experience using a model with single flow rate and new design for modulated insulin infusionH Buchwald, T D Rohde, F D Dorman, et al.
International Journal of Obesity (2005)|February 28, 2007
Inter-disciplinary European guidelines on surgery of severe obesityM Fried, V Hainer, A Basdevant, et al.
Archives of Internal Medicine|June 13, 1998
Effective lipid modification by partial ileal bypass reduced long-term coronary heart disease mortality and morbidity: five-year posttrial follow-up report from the POSCH. Program on the Surgical Control of the HyperlipidemiasH Buchwald, R L Varco, J R Boen, et al.
Surgery|October 1, 1982
The Program on the Surgical Control of the Hyperlipidemias: a status reportH Buchwald, R B Moore, J P Matts, et al.
Journal of Medicinal Chemistry|April 1, 2026
An Optimized Route to the Syringolin Natural Products Enables Combinatorial Synthesis of Selective, Bioactive Inhibitors of the <i><i>Plasmodium falciparum</i></i> 20S ProteasomeXilin Gu, Pavla Fajtova, Nicholas L Yan, et al.
Pageof 11